Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy (IMAGE)

Bentham Science Publishers

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Caption

Some PI3K, Akt and mTOR inhibitors have been tested as cancer therapeutic agents alone or in combination with standard therapies and showed sensitizing effects with radio-, hormone and chemo-therapy.

Credit

Dr. Festuccia Claudio

Usage Restrictions

Copyrights belong to Dr. Festuccia Claudio and Bentham Science Publishers

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.